SCHEMBL719837

SCHEMBL719837

O=C1C=CC(=O)N1c1cccc2cc3ccccc3cc12

nearest known ligand 0.57

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TLR9 Q9NR96 2/20 0.57
HSP90AA1 P07900 3/20 0.50
MGLL Q99685 13/20 0.48
FAAH O00519 3/20 0.44
POLB P06746 1/20 0.44
ALDH1A1 P00352 4/20 0.41
PKM P14618 3/20 0.41
ATM Q13315 2/20 0.41
CCR6 P51684 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
KDM4E B2RXH2 1/20 0.41
GAA P10253 1/20 0.41
HTT P42858 1/20 0.41
MAPT P10636 1/20 0.41
HPGD P15428 1/20 0.41
HSD17B10 Q99714 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31387987 1.00 TLR9 (0.57) TLR9HSP90AA1MGLLFAAHPOLB
SCHEMBL719069 0.98 TLR9 (0.55) TLR9HSP90AA1MGLLFAAHPOLB
SCHEMBL723971 0.98 TLR9 (0.55) TLR9HSP90AA1MGLLFAAHPOLB
SCHEMBL152339 0.82 TLR9 (0.64) TLR9HSP90AA1MGLLFAAHPOLB
SCHEMBL29386767 0.82 TLR9 (0.64) TLR9HSP90AA1MGLLFAAHPOLB
SCHEMBL19511616 0.80 TLR9 (0.65) TLR9HSP90AA1MGLLFAAHALDH1A1
SCHEMBL4072228 0.80 TLR9 (0.50) TLR9HSP90AA1MGLLFAAHPOLB
SCHEMBL30497722 0.80 TLR9 (0.50) TLR9HSP90AA1MGLLFAAHPOLB
SCHEMBL31179984 0.79 HSP90AA1 (0.61) TLR9HSP90AA1MGLLFAAHPOLB
SCHEMBL31179946 0.79 HSP90AA1 (0.61) TLR9HSP90AA1MGLLFAAHPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 111 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025090402-A1 DEBONDABLE ADHESIVE Geisys Ventures, LLC (US) 2025-05-01 WO claimed
CN-111303657-A Microcapsule type dye and preparation method and application method thereof TCL华星光电技术有限公司 2020-06-19 CN claimed
US-20180044495-A1 REVERSIBLY CROSS-LINKABLE RESIN OWENS CORNING INTELLECTUAL CAPITAL, LLC 2018-02-15 US claimed
CN-121895257-A High-stability single-donor binary crosslinked organic photoelectric material, and preparation method and application thereof 广州大学 2026-04-21 CN disclosed
US-20260099051-A1 INJECTION MOLDED LIGHT-GUIDING MEMBER AND HEAD-MOUNTED DISPLAY ASAHI KASEI KABUSHIKI KAISHA (JP) 2026-04-09 US disclosed
US-20260036719-A1 REFLECTIVE POLARIZER BONDED LENS, HEAD-MOUNTED DISPLAY, AND METHOD FOR PRODUCING REFLECTIVE POLARIZER BONDED LENS ASAHI KASEI KABUSHIKI KAISHA (JP) 2026-02-05 US disclosed
US-12512430-B2 Metallization method DUPONT ELECTRONIC MATERIALS INTERNATIONAL, LLC (US) 2025-12-30 US disclosed
US-12503455-B2 Nucleic acid-binding photoprobes and uses thereof ARRAKIS THERAPEUTICS, INC. (US) 2025-12-23 US disclosed
EP-4605011-A2 POLYPEPTIDYL LINKERS Quantum-Si Incorporated (US) 2025-08-27 EP disclosed
US-20250223396-A1 GLYCIDYL ETHER GROUP-CONTAINING COMPOUND, CURABLE RESIN COMPOSITION, CURED PRODUCT, AND LAMINATE DIC CORPORATION (JP) 2025-07-10 US disclosed
US-20250179237-A1 GLYCIDYL ETHER GROUP-CONTAINING COMPOUND, CURABLE RESIN COMPOSITION, CURED PRODUCT, AND LAMINATE DIC CORPORATION (JP) 2025-06-05 US disclosed
US-7771695-B2 Complexes of carbon nanotubes and fullerenes with molecular-clips and use thereof INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2010-08-10 US disclosed
US-20100170418-A1 COMPLEXES OF CARBON NANOTUBES AND FULLERENES WITH MOLECULAR-CLIPS AND USE THEREOF INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2010-07-08 US disclosed
US-20100099798-A1 REVERSIBLE VISCOSITY REDUCING POLYMER UNITED STATES OF AMERICA, THE, AS REPRESENTED BY THE ARMY SECRETARY OF THE 2010-04-22 US disclosed
CN-101489927-A Complexes of carbon nanotubes and fullerences with molecular-clips and use thereof IBM (US) 2009-07-22 CN disclosed
EP-2076463-A2 COMPLEXES OF CARBON NANOTUBES AND FULLERENCES WITH MOLECULAR-CLIPS AND USE THEREOF International Business Machines Corporation (US) 2009-07-08 EP disclosed
WO-2008048732-A2 COMPLEXES OF CARBON NANOTUBES AND FULLERENES WITH MOLECULAR-CLIPS AND USE THEREOF INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2008-04-24 WO disclosed
WO-2008011623-A2 COMPLEXES OF CARBON NANOTUBES AND FULLERENES WITH MOLECULAR-CLIPS AND USE THEREOF INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2008-01-24 WO disclosed
US-20070196592-A1 Stretched Film, Process For The Production Thereof And Laminated Material TEIJIN DUPONT FILMS JAPAN LIMITED 2007-08-23 US disclosed
EP-1743915-A1 ORIENTED FILM, PROCESS FOR PRODUCING THE SAME AND LAMINATE THEREOF Teijin Dupont Films Japan Limited (JP) 2007-01-17 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100170418-A1 COMPLEXES OF CARBON NANOTUBES AND FULLERENES WITH MOLECULAR-CLIPS AND USE THEREOF CYCS, PCNA, DYNC1LI2 TLR9 2971/4885HSP90AA1 2622/4885MGLL 3726/4885
US-12512430-B2 Metallization method CUTA, AS3MT, METTL14 TLR9 288/4885HSP90AA1 4393/4885MGLL 1069/4885
US-20260099051-A1 INJECTION MOLDED LIGHT-GUIDING MEMBER AND HEAD-MOUNTED DISPLAY NR2E3, STRA6, UACA TLR9 3039/4885HSP90AA1 3102/4885MGLL 454/4885
US-12503455-B2 Nucleic acid-binding photoprobes and uses thereof NSUN3, NSUN2, TARBP1 TLR9 2835/4885HSP90AA1 851/4885MGLL 4589/4885
US-20260036719-A1 REFLECTIVE POLARIZER BONDED LENS, HEAD-MOUNTED DISPLAY, AND METHOD FOR PRODUCING REFLECTIVE POLARIZER BONDED LENS VCL, CDH1, DSP TLR9 3532/4885HSP90AA1 133/4885MGLL 2681/4885
US-20180044495-A1 REVERSIBLY CROSS-LINKABLE RESIN FRG1, MTCL3, FGB TLR9 3751/4885HSP90AA1 400/4885MGLL 512/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.